日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Personalized Decision-Making in Risk-Reducing Surgery of the Ovaries

卵巢风险降低手术中的个性化决策

Daly, Mary B; Egleston, Brian L; Lew, Kaitlyn; Bealin, Lisa; Husband, Alexander; Stopfer, Jill E; Przybysz, Pawel; Tchuvatkina, Olga; Wong, Yu-Ning; Garber, Judy E; Rebbeck, Timothy R

Genetic Testing for All Breast Cancer Patients: The GET FACTS Randomized Clinical Trial

所有乳腺癌患者均应进行基因检测:GET FACTS随机临床试验

Weiss, Anna; Braun, Danielle; Stopfer, Jill; Zhao, Jintong; McGrath, Monica; Bradshaw, Kaitlyn R; Rosito, Maria Sol; Davis, Dillon; Garber, Judy E; King, Tari A

Glands of Moll: history, current knowledge and their role in ocular surface homeostasis and disease

莫尔氏腺:历史、现状及其在眼表稳态和疾病中的作用

Stopfer, Michael; Zahn, Ingrid; Jüngert, Katharina; Aumüller, Gerhard; Moll, Frans L; Schicht, Martin; Makarenkova, Helen P; de Paiva, Cintia S; Paulsen, Friedrich P

Corrigendum to "Glands of Moll: history, current knowledge and their role in ocular surface homeostasis and disease" [Progr. Retin. Eye Res. 106 (2025) 101362]

对“Moll腺:历史、当前知识及其在眼表稳态和疾病中的作用”的更正[Progr. Retin. Eye Res. 106 (2025) 101362]

Stopfer, Michael; Zahn, Ingrid; Jüngert, Katharina; Aumüller, Gerhard; Moll, Frans L; Schicht, Martin; Makarenkova, Helen P; de Paiva, Cintia S; Paulsen, Friedrich P

Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy

经基因工程改造的抗体能够稳定药物修饰的KRASG12C新抗原,从而实现选择性强、疗效显著的跨HLA免疫疗法。

Lorenzo Maso #,Sarah A Mosure #,Sergio A Rodriguez-Aponte,Angelina Pizzo,Diamond N Mensah,Matthew Southard,Samantha Sze,Tanvir Ahmed,Brian Vash,Takamitsu Hattori,Epsa Rajak,Akiko Koide,Benjamin G Neel,Shohei Koide,Weifeng Liu,Sean T Toenjes,Paul Da Silva Jardine,Rajesh Chopra,Christoph Rader,Lauren E Stopfer

Validation and quantification of peptide antigens presented on MHCs using SureQuant

利用 SureQuant 对 MHC 上呈递的肽抗原进行验证和定量

Owen Leddy ,Yufei Cui ,Ryuhjin Ahn ,Lauren Stopfer ,Elizabeth Choe ,Do Hun Kim ,Malte Roerden ,Stefani Spranger ,Bryan D Bryson ,Forest M White

Improving the Working Models for Drug-Drug Interactions: Impact on Preclinical and Clinical Drug Development

改进药物相互作用的工作模型:对临床前和临床药物研发的影响

Nguyen, James; Joseph, David; Chen, Xin; Armanios, Beshoy; Sharma, Ashish; Stopfer, Peter; Huang, Fenglei

Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs

评估溶解度限制吸收作为预测 BCS II/IV 类药物食物效应的替代指标

Rodriguez-Fernandez, Karine; Gómez-Mantilla, José David; Shukla, Suneet; Stopfer, Peter; Sieger, Peter; Mangas-Sanjuán, Victor; Peters, Sheila Annie

Changes in Risk Tolerance for Ovarian Cancer Prevention Strategies during the COVID-19 Pandemic: Results of a Discrete Choice Experiment

新冠疫情期间卵巢癌预防策略风险承受能力的变化:一项离散选择实验的结果

Egleston, Brian L; Daly, Mary B; Lew, Kaitlyn; Bealin, Lisa; Husband, Alexander D; Stopfer, Jill E; Przybysz, Pawel; Tchuvatkina, Olga; Wong, Yu-Ning; Garber, Judy E; Rebbeck, Timothy R

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

一项关于两种远程医疗服务模式对胰腺癌患者家庭基因检测接受度及患者自述心理健康状况影响的随机对照试验:基因教育、风险评估和检测(GENERATE)研究

Rodriguez, Nicolette J; Furniss, C Sloane; Yurgelun, Matthew B; Ukaegbu, Chinedu; Constantinou, Pamela E; Fortes, Ileana; Caruso, Alyson; Schwartz, Alison N; Stopfer, Jill E; Underhill-Blazey, Meghan; Kenner, Barbara; Nelson, Scott H; Okumura, Sydney; Zhou, Alicia Y; Coffin, Tara B; Uno, Hajime; Horiguchi, Miki; Ocean, Allyson J; McAllister, Florencia; Lowy, Andrew M; Klein, Alison P; Madlensky, Lisa; Petersen, Gloria M; Garber, Judy E; Lippman, Scott M; Goggins, Michael G; Maitra, Anirban; Syngal, Sapna